Home

JOSEPH J GRANO JR

CIK 1304755 · CEO and Chairman · last filed 2026-08-20

JOSEPH J GRANO JR is a CEO and Chairman who has filed 38 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider sold $511.9K of VIRT on Aug 20, 2026. Across all open-market trades the lifetime net is −$642.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.6M across reported positions. 9 SEC filings were submitted jointly with Virtu Financial, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.56M

Companies

6

Total Filings

38

Lifetime Open-Market Net

-$642.1K

Filer Profile

Reported Address
C/O MEDGENICS, INC.
435 DEVON PARK DRIVE BLDG 700
WAYNE, PA 19087
Related Filers
Virtu Financial, Inc. — 9 joint filings, latest 2026-08-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VIRT Director 33,814 $57.94 $1.96M -$511.9K 7 2026-08-20
GNMX Director 102,683 $35.03 $3.60M $28.9K 5 2018-11-13
root9B Holdings, Inc. (RTNB) Delisted CEO and Chairman — — — $0 1 2017-01-27
Aevi Genomic Medicine, LLC (MDGN) Delisted Director 74,164 — — -$15.8K 2 2016-12-12
Aevi Genomic Medicine, LLC (MDGN.WS) Delisted Director 71,164 — — $300.0K 5 2015-10-08
AMERITYRE CORP (AMTY) Delisted 76,367 — — -$443.4K 5 2008-01-17

Recent Filings

38 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-20 VIRT Sell (S) −8,400 -$511.9K EDGAR
2026-08-19 VIRT Notice (144) −8,400 -$511.9K EDGAR
2026-07-06 VIRT Mixed +3,392 $0 EDGAR
2025-07-03 VIRT Mixed +6,681 $0 EDGAR
2024-07-03 VIRT Mixed +8,760 $0 EDGAR
2023-07-03 VIRT Mixed +6,365 $0 EDGAR
2022-07-01 VIRT Mixed +4,880 $0 EDGAR
2021-07-02 VIRT Mixed +5,811 $0 EDGAR
2020-02-05 — Disp (D) −174,847 $0
2018-11-13 GNMX Buy (P) +68,000 $78.9K EDGAR
Showing 1–10 of 38
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.